Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

30/07/2014 Barcelona among the top 10 cities in the world 24/07/2014 Researchers prove the effectiveness of a new drug against malaria using synchrotron light 17/07/2014 Creation of the Health Technologies Cluster 10/07/2014 An international team of scientists led by researchers from the UAB creates the world's first magnetic hose 03/07/2014 CaixaBank and Oracle set up a Big Data Centre of Excellence in the Barcelona Synchrotron Park 26/06/2014 The Barcelona Supercomputing Center hosts two important new international projects
39 40 41 42 43 44 45 46 47 48 49